Friday, Feb 14 2025 | Time 10:37 Hrs(IST)
image
Business Economy


Granules India net profit down 6 percent to INR 1,176 Mn in Q3 FY25

Hyderabad, Jan 24 (UNI) Granules India Ltd., a vertically integrated pharmaceutical company, on Friday reported a 6 percent down in its net profit to INR 1,176 Million for the quarter ended December 31, 2024, as compared to INR 1,257 million in the year-ago period.
Hyderabad-based Pharma Company's revenue from operations during the quarter also declined 2 percent to INR 11,377 million as compared to INR 11,556 million in the corresponding period in the previous year.
The Company voluntarily paused production at the Gagillapur plant on Sep-24 for risk assessment on account of the US FDA observations.
Subsequently, the production resumed in October in a staggered manner, the pharma company said in a release here.
Revenue share from North America increased to 77 percent in Q3 FY25, compared to 66 percent in the corresponding period in FY24.
Finished dosages (FD), Active Pharmaceuticals Ingredients (API), and Pharmaceutical Formulation Intermediates (PFI) contributed 76 percent, 12 percent, and 12 percent of revenue from operations respectively for Q3FY25.
The company’s net debt stood at INR 8,289 million
Commenting on the results, Dr Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “We continue to sustain our profitable growth in the finished dosages segment, driven by our North America business. We are enhancing quality and compliance through systemic improvements across our operations, including Gagillapur. Progress on our greenfield formulation expansion at GLS remains on track, reinforcing our capabilities and driving future growth.”
The Company has 10 manufacturing facilities out of which 8 are in India and 2 in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, KFDA, DEA, MCC, and HALAL.
UNI KNR BD
More News

Invest Kerala Global Summit to focus on key sectors

13 Feb 2025 | 8:59 PM

Thiruvananthapuram, Feb 13 (UNI) The ‘Invest Kerala Global Summit’ (IKGS 2025), scheduled in Kochi on February 21 to 22, will focus on generating investments in key sectors, especially those identified by the government’s New Industrial Policy (NIP) calibrating the state’s core potential.

see more..

Jubilant Biosys seals deal with Pierre Fabre SA

13 Feb 2025 | 8:05 PM

New Delhi, Feb 13 (UNI) Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, has executed the transaction definitive agreements with Pierre Fabre SA, and its affiliate entities, for JBIRSPL to acquire 80 percent equity capital in JASMIN (new company incorporated by PF in France), with remaining 20 percent retained by PF.

see more..
RBI Guv meets MDs, CEOs of NBFCs; stresses for sound practices for inclusive development

RBI Guv meets MDs, CEOs of NBFCs; stresses for sound practices for inclusive development

13 Feb 2025 | 5:51 PM

Mumbai, Feb 13 (UNI) RBI Governor Sanjay Malhotra on Thursday held a meeting with the Managing Directors and CEOs of select Non-Banking Financial Companies (NBFCs) across all layers, including Government NBFCs, Housing Finance Companies and Micro-Finance Institutions and stressed upon balancing growth aspirations with sound practices for ensuring inclusive development, customer protection and financial stability.

see more..

Kottayam-Kochi Rubber Market Rates

13 Feb 2025 | 5:50 PM

Kottayam Feb 13(UNI) Following were the Rubber Market rates announced by the Rubber Board here on Thursday per quintal.

see more..
Amazon and DGFT extend collaboration to accelerate ecommerce exports from India

Amazon and DGFT extend collaboration to accelerate ecommerce exports from India

13 Feb 2025 | 4:54 PM

Kolkata, Feb 13 (UNI) Amazon and the Directorate General of Foreign Trade (DGFT) on Thursday announced an extension of their collaboration to accelerate ecommerce exports from India.

see more..
image